论文部分内容阅读
目的:探讨川芎嗪联合卡托普利治疗慢性肺源性心脏病心力衰竭的临床疗效。方法:回顾性分析我院近年来收治的90例慢性肺源性心脏病心力衰竭患者的临床资料。结果:观察组45例患者,总有效率为91.11%,明显高于对照组,经统计学比较分析,P<0.05,差异具有统计学意义。观察组治疗后的血气指标PH、PaO2、PaCO2均较对照组有明显改善,经统计学分析,P<0.05,差异具有统计学意义。结论:川芎嗪联合卡托普利治疗慢性肺源性心脏病心力衰竭的临床疗效确切,值得推广使用。
Objective: To investigate the clinical efficacy of ligustrazine plus captopril in the treatment of heart failure with chronic cor pulmonale. Methods: The clinical data of 90 patients with chronic cor pulmonale heart failure treated in our hospital in recent years were retrospectively analyzed. Results: The observation group of 45 patients, the total effective rate was 91.11%, significantly higher than the control group, the statistical analysis, P <0.05, the difference was statistically significant. The observation group after treatment, blood gas indicators PH, PaO2, PaCO2 were significantly improved compared with the control group, the statistical analysis, P <0.05, the difference was statistically significant. Conclusion: Tetramethylpyrazine combined with captopril in the treatment of chronic cor pulmonale heart failure clinical efficacy is exact, it is worth promoting the use of.